🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

CNO Financial stock remains a Buy with potential growth from distribution recovery

EditorAhmed Abdulazez Abdulkadir
Published 13/09/2024, 14:56
CNO
-


On Friday, Piper Sandler confirmed its Overweight rating on CNO Financial Group (NYSE:NYSE:CNO) with a steady price target of $37.00. The firm highlighted CNO's strong positioning within the life insurance sector, noting several factors contributing to its positive outlook. The distribution network for CNO has seen a revival, supported by both recruitment trends and a broader, secular demand tailwind.


The analyst from Piper Sandler also pointed out that CNO's liability portfolio is not overly concentrated in legacy liabilities, which could be seen as a positive in the current market environment. Additionally, CNO's expense structure could see benefits from recent strategic actions taken by the company.


Further strengthening the case for CNO Financial Group, the analyst mentioned that with the company nearly a year after establishing CNO Bermuda, it would not be surprising to see it working on subsequent initiatives for the entity. This move could potentially enhance the company's growth trajectory and operational efficiency.


Lastly, the valuation of CNO Financial Group was described as attractive, especially in a segment of the life insurance market that is experiencing consolidation and heightened interest in owned distribution channels.

InvestingPro Insights


Adding to the optimism from Piper Sandler, InvestingPro data and tips further illuminate the financial health and performance of CNO Financial Group. The company's management has been actively repurchasing shares, signaling confidence in the business. Additionally, CNO Financial has a track record of raising its dividend, with a history of 12 consecutive years of increases, underscoring its commitment to returning value to shareholders.


From a valuation perspective, CNO Financial is trading at a low P/E ratio of 8.29, which is attractive relative to its near-term earnings growth potential. The company's PEG ratio, which stands at a mere 0.14 as of the last twelve months ending Q2 2024, suggests that the stock may be undervalued considering its growth rate. Moreover, with a robust revenue growth of 11.08% over the same period, CNO demonstrates a strong financial performance.


InvestingPro Tips also highlight that analysts have revised their earnings estimates upwards for the upcoming period, and the company is expected to remain profitable this year. For investors seeking additional insights, there are over 9 more InvestingPro Tips available, offering a deeper dive into CNO Financial's prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.